期刊文献+

临床药师参与1例慢性阻塞性肺疾病急性加重患者的抗感染治疗及药学监护

Clinical Pharmacists'Participation in the Anti-infective Treatment and Pharmaceutical Care of A Patient with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
暂未订购
导出
摘要 目的探讨伴肺部感染的慢性阻塞性肺疾病急性加重(AECOPD)患者的抗感染治疗及药学监护要点,为该类患者的科学治疗提供参考。方法抗感染专业临床药师以会诊形式,参与1例伴有肺部感染的AECOPD患者的抗感染治疗。依据患者实际病情,协同医生拟定并适时调整抗感染治疗方案,同时全面开展药学监护工作。结果临床药师介入抗感染治疗和药学监护后,患者肺部感染及AECOPD病情得到有效控制,用药过程中的不良反应减少,疗效和用药安全得以保障。结论临床药师凭借专业优势,制定科学且个体化的抗感染诊疗方案,成功救治伴肺部感染的AECOPD患者,提高了临床用药的疗效与安全性。 Objective To investigate the anti-infection treatment and key points of pharmaceutical care for patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD)accompanied by pulmonary infection,providing references for the scientific treatment of such patients.Methods An anti-infection-specialized clinical pharmacist participated in the anti-infection treatment of a patient with AECOPD accompanied by pulmonary infection through consultation.Based on the patient's actual condition,the pharmacist collaborated with the doctor to formulate and timely adjust the anti-infection treatment plan and simultaneously conducted comprehensive pharmaceutical care.Results After the clinical pharmacist intervened in the anti-infection treatment and pharmaceutical care,the patient's pulmonary infection and AECOPD were effectively controlled,adverse reactions during medication were reduced,and the patient's therapeutic effect and medication safety were guaranteed.Conclusion Relying on their professional advantages,clinical pharmacists assist doctors in formulating scientific and individualized anti-infection plans,successfully treating patients with AECOPD accompanied by pulmonary infection and enhancing the efficacy and safety of clinical medication.
作者 胡智 胥甜甜 刘剑 刘建明 HU Zhi;XU Tiantian;LIU Jian;LIU Jianming(The First Affiliated Hospital of Nanchang University,Nanchang Jiangxi 330006,China)
出处 《药品评价》 2025年第3期338-341,共4页 Drug Evaluation
关键词 慢性阻塞性肺部疾病 抗感染治疗 药学监护 药学会诊 临床药师 Chronic obstructive pulmonary disease Anti-infective treatment Pharmaceutical care Pharmaceutical consultation Clinical pharmacist
  • 相关文献

参考文献7

二级参考文献96

  • 1俞森洋.慢性阻塞性肺病和哮喘的雾化吸入疗法[J].中国药物应用与监测,2006,3(4):28-31. 被引量:11
  • 2慢性阻塞性肺疾病急性加重患者机械通气指南(2007)[J].中华急诊医学杂志,2007,16(4):350-357. 被引量:250
  • 3Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007; 176: 753-760.
  • 4Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347: 465-471.
  • 5Rothberg MB, Pekow PS, Lahti M, Brody 0, Skiest DJ, Lindenauer PK. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA 2010; 303: 2035-2042.
  • 6Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196- 204.
  • 7National Committee for Clinical Laboratory Standards. National Committee for Clinical Laboratory Standards, Wayne, Pa. Performance standards for antimicrobial susceptibility testing. 2004; MI00-SI4.
  • 8Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
  • 9Ko FW, Ng TK, Li TS, Fok JP, Chan MC, WuAK, et al. Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong. Respir Med 2005; 99: 454-460.
  • 10Hui DS, 1p M, Ling T, Chang SC, Liao CH, Yoo CG, et al. A multicentre surveillance study on the characteristics, bacterial aetiologies and in vitro antibiotic susceptibilities in patients with acute exacerbations of chronic bronchitis. Respirology 20 II; 16: 532-539.

共引文献557

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部